30,900 Shares in Schrodinger, Inc. $SDGR Bought by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. acquired a new stake in Schrodinger, Inc. (NASDAQ:SDGR) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 30,900 shares of the company’s stock, valued at approximately $502,000.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Schrodinger during the second quarter worth about $170,978,000. Vanguard Group Inc. increased its stake in shares of Schrodinger by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 6,464,426 shares of the company’s stock valued at $115,584,000 after acquiring an additional 125,349 shares during the last quarter. Rubric Capital Management LP raised its position in shares of Schrodinger by 43.8% in the 1st quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company’s stock valued at $68,160,000 after acquiring an additional 1,828,502 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Schrodinger by 12.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,717,890 shares of the company’s stock valued at $66,476,000 after acquiring an additional 414,231 shares during the period. Finally, Amova Asset Management Americas Inc. boosted its stake in Schrodinger by 13.2% during the 1st quarter. Amova Asset Management Americas Inc. now owns 3,190,837 shares of the company’s stock worth $36,248,000 after acquiring an additional 371,167 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

SDGR has been the subject of a number of analyst reports. Morgan Stanley decreased their price objective on shares of Schrodinger from $19.00 to $17.00 and set an “equal weight” rating for the company in a report on Thursday, May 14th. UBS Group began coverage on shares of Schrodinger in a research report on Friday, August 14th. They set a “neutral” rating and a $19.00 price target on the stock. Weiss Ratings lowered shares of Schrodinger from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 12th. Finally, Wall Street Zen upgraded shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research report on Saturday, August 8th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Schrodinger has a consensus rating of “Hold” and a consensus price target of $20.50.

Schrodinger Stock Performance

Shares of SDGR opened at $19.71 on Friday. The stock has a 50 day simple moving average of $16.45 and a 200 day simple moving average of $13.94. Schrodinger, Inc. has a 52-week low of $10.94 and a 52-week high of $23.02. The firm has a market capitalization of $1.45 billion, a PE ratio of -26.63 and a beta of 1.63.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, August 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The firm had revenue of $58.89 million for the quarter, compared to the consensus estimate of $47.19 million. During the same period last year, the company posted ($0.65) EPS. The business’s quarterly revenue was up 7.5% on a year-over-year basis. Equities research analysts predict that Schrodinger, Inc. will post -1.89 EPS for the current fiscal year.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.